Dr. Ted Driscoll brings 30 years of experience in health and imaging technology as an investor and entrepreneur. He is an expert on digital health and diagnostics, from big data and health technology to genomics and personalized medicine.
Dr. Driscoll has a successful track record of sourcing and leading the financing of promising digital healthcare startup companies, including Natera, GeneWeave BioSciences, and AssureX Health. He currently represents Claremont Creek Venture (CCV) on the boards of Natera, AssureX, Numedii, Zipline Medical, GeneWeave, and Prime Genomics. He has previously served as a board member of Tibion (acquired by AlterG), GigaGen, and Fluxion Biosciences.
Prior to CCV, Dr. Driscoll founded five successful companies in imaging-related markets. He was founder and CEO of Be Here Technologies, a pioneer in Internet, Broadcast, and Videoconferencing Technologies (now part of Google StreetView). He also served as CEO of Focus Surgery, spun off from Diasonics, and was previously Division President and CTO of Diasonics, with responsibility for its MRI, ultrasound, digital X-ray, and ablation technology businesses. Earlier, he led the Diasonics team that developed the first commercial MRI scanners. Previously, Dr. Driscoll was also Vice President of Engineering at Identix, then a world leader in digital fingerprint recognition (now used in the iPhone); and was Director of R&D at International Imaging Systems, an early pioneer in satellite remote sensing.
Dr. Driscoll was an angel investor with Life Science Angels and a founding director of the Sand Hill Angels and Health Tech Capital. He also has served as an elected council member of his hometown, Portola Valley, for 20 years and five terms as Mayor.
Dr. Driscoll holds a Ph.D. from Stanford University in Digital Imaging, two Masters degrees from Harvard University in Computer Graphics and Remote Sensing and a Bachelor’s degree from the University of Pennsylvania. He holds more than 50 granted the US and foreign patents in imaging-related fields.